Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented John Deere in the transaction. Deere & Company (NYSE: DE) has signed a definitive agreement to acquire Bear Flag Robotics for US$250...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Phononic in the transaction. Phononic, a global leader in sustainable solid-state cooling and heating technology, has secured a significant growth investment of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Imago BioSciences, Inc. in the offering. Imago BioSciences, Inc. (Imago) (NASDAQ: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MNTN in the transaction. Mountain (MNTN), a leading self-serve performance TV platform, executed the acquisition of Maximum Effort Marketing, Ryan Reynolds and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Duolingo, while Skadden, Arps, Slate, Meagher & Flom advised the bookrunners on the deal. Duolingo has publicly filed a registration statement with the U.S....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Thumbtack in the transaction. Thumbtack, the modern home management platform, has secured a US$275 million investment at a valuation of US$3.2 billion....
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Cloudera, Kirkland advised affiliates of Clayton, Dubilier & Rice and KKR, while Debevoise & Plimpton LLP advised Clayton, Dubilier & Rice...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Ro in the transaction. Ro, the healthcare technology company, has announced the acquisition of Modern Fertility, a high-growth reproductive health company...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...
You must be a Standard 1 Year member to access this content.
